LncRNA H19 is a major mediator of doxorubicin chemoresistance in breast cancer cells through a cullin4A-MDR1 pathway

Development of chemoresistance is a persistent problem during cancer treatment. Long non-coding RNAs (LncRNAs) are currently emerging as an integral functional component of the human genome and as critical regulators of cancer development and progression. In the present study, we investigated the ro...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhu, Qiong-Ni, Wang, Guo, Guo, Ying, Peng, Yan, Zhang, Rui, Deng, Jun-Li, Li, Zhi-Xing, Zhu, Yuan-Shan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5696158/
https://www.ncbi.nlm.nih.gov/pubmed/29190892
http://dx.doi.org/10.18632/oncotarget.21121

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5696158/
https://www.ncbi.nlm.nih.gov/pubmed/29190892
http://dx.doi.org/10.18632/oncotarget.21121

Ejemplares similares